Le Lézard
Classified in: Health
Subject: FDA

G21® announces the FDA Clearance of SpaceFlex Shouldertm : The unique complete line of Custom Modular Spacers available worldwide


SAN POSSIDONIO, Italy, Feb. 24, 2021 /PRNewswire/ -- G21® S.r.l., a bone cement manufacturer company, is pleased to announce the clearance of SpaceFlex Shouldertm as a completion of its existing Spaceflex line: Hip and Knee.

G21® announces the FDA Clearance of SpaceFlex Shouldertm : The unique complete line of Custom Modular Spacers available worldwide

"The achievement of this result for G21® S.r.l. means being able to offer a dedicated treatment of each infected joint," says Filippo Foroni, Executive Vice President of G21® S.r.l. "Since we set up the company in 2009, we are committed to provide our patients with better health conditions. The addition of SpaceFlex Shouldertm to our product portfolio represents a user-friendly solution for complex issues."

About G21® S.r.l.

G21® S.r.l. offers a range of products for both orthopedics and minimally invasive spine surgery.  G21® S.r.l. provides bone cement for orthopedics with different levels of viscosity for the making of temporary prothesis for the treatment of infections and septic revisions. G21® S.r.l. supplies bone cement for vertebral consolidation for the performing of minimally invasive spine surgeries such as vertebroplasty and kyphoplasty procedures.

SpaceFlex Shouldertm is officially available on the US Market.

The company's website for new releases and further information is www.g-21.it

https://www.linkedin.com/company/g21-srl

G21 Logo

Photo: https://mma.prnewswire.com/media/1442833/G21_SpaceFlex_Shoulder.jpg

Logo: https://mma.prnewswire.com/media/1442832/G21_Logo.jpg


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....



News published on and distributed by: